Equities

Poolbeg Pharma PLC

POLB:LSE

Poolbeg Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4.60
  • Today's Change0.20 / 4.55%
  • Shares traded2.55m
  • 1 Year change-10.68%
  • Beta2.0717
Data delayed at least 20 minutes, as of Feb 06 2026 16:42 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy1
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast

The one analyst offering a 12 month price target expects Poolbeg Pharma PLC share price to rise to 19.00 in the next year from the last price of 4.40.
High331.8%19.00
Med331.8%19.00
Low331.8%19.00

Earnings history & estimates

Poolbeg Pharma PLC reported annual 2024 losses of -1.16 per share on May 20, 2025.
Average growth rate-15.44%
More ▼

Revenue history & estimates

Poolbeg Pharma PLC did not report revenues for the full year 2024. However, during the prior year the company reported revenues of 0.00.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.